Skinvisible Web Sign Up for Updates         T 702.433.7154   |   F 702.433.7192
Skinvisible - Polymer Delivery System

The Ultimate Polymer Delivery System.
Skinvisible's value lies in its ability to continually generate new IP on dermatology and medical products formulated with Invisicare®. Patent approvals are sought (initially in the U.S. and later internationally) for all products developed. There are 4 patents approved, 9 U.S. patents pending in addition to 34 PCTs internationally, with many more to be filed. Some of these PCT patents cover up to five products. All patents with Invisicare® are owned by Skinvisible.

Patent Components (Combined or Individually):



Granted Patents & Trademarks

United States Patents Granted

United States Patent No.:   7,674,471
Granted:   March 9, 2010
Topical composition, topical composition precursor, and methods for manufacturing and using.

United States Patent No.:  6,756,059
Granted:  June 29, 2004
Topical composition, topical composition precursor, and methods for manufacturing and using.

United States Patent No.:  6,582,683
Granted:  June 24, 2003
Dermal barrier composition.


International Patents Granted

India Patent
Granted:  July 26, 2007
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

Australia Patent
Granted:  June 3, 2008
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

Japan Patent
Granted:  October 31, 2008
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

China Patent
Granted:  July 1, 2009
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

Korea Patent
Granted:  February 9, 2010
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

Hong Kong Patent
Granted:  July 27, 2010
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

Canada Patent
Granted:  February 22, 2011
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

Latest Press Releases:


October 12, 2011
Skinvisible’s DermSafe Hand Sanitizer Recommended by the Dermatology Review Panel - Alcohol-free Hand Sanitizer with Invisicare Receives Dermatologists’ Seal of Approval

September 22, 2011
Skinvisible Receives European Patent Notice for Invisicare - Drug Delivery Technology Protected on Four Continents

August 18, 2011
Skinvisible's DermSafe Hand Sanitizer to Launch in Canada - Hand Sanitizer Made Without Alcohol Available Just in Time for Flu Season

July 18, 2011
Skinvisible Licensee Launches First Prescription Product in the USA - Womens Choice Pharmaceuticals Introduces ProCort® Hemorrhoid Treatment

April 27, 2011
Skinvisible Licensee Receives First European Approval for Hand Sanitizer - Rhei Pharmaceuticals to Launch HandSafe in Belgium

Skinvisible Shareholder Update 2011



CLICK HERE TO READ ALL NEWS RELEASES



  Research & Development
  Technology Overview
Home    |     About us    |    Technology    |    Products    |    Investors    |    Contact Us    |    Disclaimer & Privacy    |     Sign Up for Updates
© 2008 Skinvisible Pharmaceuticals, Inc.     Note: This website is not intended for Canadian residents.